264 related articles for article (PubMed ID: 24692589)
21. Use of Embryonic Stem Cells to Treat Severe Eye Diseases.
Aznar J; Tudela J
Cuad Bioet; 2016; 27(90):241-7. PubMed ID: 27637197
[TBL] [Abstract][Full Text] [Related]
22. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
23. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.
Galende E; Karakikes I; Edelmann L; Desnick RJ; Kerenyi T; Khoueiry G; Lafferty J; McGinn JT; Brodman M; Fuster V; Hajjar RJ; Polgar K
Cell Reprogram; 2010 Apr; 12(2):117-25. PubMed ID: 20677926
[TBL] [Abstract][Full Text] [Related]
24. Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.
Barczyk M; Schmidt M; Mattoli S
Stem Cell Rev Rep; 2015 Aug; 11(4):598-620. PubMed ID: 25896401
[TBL] [Abstract][Full Text] [Related]
25. The ethics of stem cells revisited.
de Miguel-Beriain I
Adv Drug Deliv Rev; 2015 Mar; 82-83():176-80. PubMed ID: 25446134
[TBL] [Abstract][Full Text] [Related]
26. Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs.
Akabayashi A; Nakazawa E; Jecker NS
Neurotherapeutics; 2020 Apr; 17(2):606-608. PubMed ID: 30924090
[TBL] [Abstract][Full Text] [Related]
27. [Regenerative therapy for post-stroke patients].
Yamashita T; Abe K
Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
[TBL] [Abstract][Full Text] [Related]
28. iPS cells--alternative pluripotent cells to embryo stem cells.
Pei X
Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
[No Abstract] [Full Text] [Related]
29. Somatic cell reprogramming as a tool for neurodegenerative diseases.
Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
[TBL] [Abstract][Full Text] [Related]
30. The future of induced pluripotent stem cells for cardiac therapy and drug development.
Thorrez L; Sampaolesi M
Curr Pharm Des; 2011 Oct; 17(30):3258-70. PubMed ID: 21919876
[TBL] [Abstract][Full Text] [Related]
31. Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.
Martínez-Cerdeño V; Barrilleaux BL; McDonough A; Ariza J; Yuen BTK; Somanath P; Le CT; Steward C; Horton-Sparks K; Knoepfler PS
Stem Cells Dev; 2017 Oct; 26(19):1409-1423. PubMed ID: 28693365
[TBL] [Abstract][Full Text] [Related]
32. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
[TBL] [Abstract][Full Text] [Related]
33. Regulatory insight into the European human pluripotent stem cell registry.
Kurtz A; Stacey G; Kidane L; Seriola A; Stachelscheid H; Veiga A
Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):51-5. PubMed ID: 25457963
[TBL] [Abstract][Full Text] [Related]
34. Current progress and potential practical application for human pluripotent stem cells.
Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
[TBL] [Abstract][Full Text] [Related]
35. [Hybrid embryos as a source of embryonic stem cells].
Beca I JP
Rev Med Chil; 2007 Nov; 135(11):1367-9. PubMed ID: 18259646
[TBL] [Abstract][Full Text] [Related]
36. Neural tissue engineering using embryonic and induced pluripotent stem cells.
Willerth SM
Stem Cell Res Ther; 2011 Apr; 2(2):17. PubMed ID: 21539726
[TBL] [Abstract][Full Text] [Related]
37. [Utilization of the ES/iPS cell technology for hematopoietic stem cell transplantation].
Otsu M; Nakauchi H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():146-50. PubMed ID: 23133943
[No Abstract] [Full Text] [Related]
38. Clinical potentials of human pluripotent stem cells.
Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
[TBL] [Abstract][Full Text] [Related]
39. Quality Assurance in Stem Cell Banking: Emphasis on Embryonic and Induced Pluripotent Stem Cell Banking.
Kallur T; Blomberg P; Stenfelt S; Tryggvason K; Hovatta O
Methods Mol Biol; 2017; 1590():11-16. PubMed ID: 28353259
[TBL] [Abstract][Full Text] [Related]
40. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
